Skip to content

Topics: Medicine

  • New method to identify mutations in childhood brain tumors

    Researchers at Uppsala university have developed a new method to find mutations in brain tumors in children. They could also show that the mutations identified by them changes how cancer cells respond to a cancer drug. These findings could lead to better diagnostics and more individualized treatment of children with brain tumors. The study is published in the journal PNAS.

  • Gut bacteria linked to fatty deposits in heart arteries

    In a major Swedish study, researchers have discovered a link between the levels of certain bacteria living in the gut and coronary atherosclerotic plaques. Such atherosclerotic plaques constitute a major cause of heart attacks. The study was led by researchers at Uppsala University and Lund University and the findings have now been published in the scientific journal Circulation.

  • High BMI elevates risk of several rheumatic diseases – but not equally for everyone

    A new study by Uppsala University shows that a higher body mass index (BMI) increases the risk of five different rheumatic diseases: rheumatism, osteoarthritis, gout, psoriatic arthritis and inflammatory spondylitis. The researchers also noted that BMI was a stronger risk factor for women compared to men in terms of gout and psoriatic arthritis. The study will be presented in the journal Arthritis

  • New study links contraceptive pills and depression

    Women who used combined contraceptive pills were at greater risk of developing depression than women who did not, according to a new study. The pills increased women’s risk by 73 per cent during the first two years of use. “Since we only investigated combined contraceptive pills in this study, we cannot draw conclusions about other contraceptive options", says leading researcher Uppsala University

  • A pro-viral human protein is critical for embryo development

    A new study has discovered that the pro-viral host protein ZC3H11A has a critical role to maintain embryo viability during early development. The study has uncovered a previously unknown function of ZC3H11A in the intricate process of embryonic growth and highlights its impact on development. The study is led by Uppsala University and INRAE/Université Paris-Saclay, now published in journal PNAS.

  • New type of drug candidate effectively accelerates wound healing in clinical study

    Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy. In a new study on humans, researchers at Uppsala University show that treatment with a specific type of modified lactic acid bacteria works well and has a positive effect on the healing of wounds.

  • Genomes from 240 mammal species explain human disease risks

    A major international research project, jointly led by Prof Kerstin Lindblad-Toh at Uppsala University and Broad Institute has surveyed and analysed the genomes of 240 different mammals. The results, now published in 11 articles in the journal Science, show how the genomes of humans and other mammals have developed over the course of evolution.

  • New artificial model validates antibodies ability to reach the brain

    A research group at Uppsala University has developed a simple and effective artificial blood-brain barrier model that can be used to determine how well antibody-based therapies can enter the brain. Today animal experimentation is the most common method for testing an antibody’s function and the new model could reduce the need for animal testing.

  • Antibiotics hindered treatment of urinary tract bacteria during the pandemic

    The use of broad-spectrum antibiotics increased drastically in intensive care at the beginning of the Covid-19 pandemic. At first, this helped patients and seemed to prevent the growth of most bacteria. However, it also contributed to a sharp growth in enterococci, an antibiotic-tolerant group of bacteria, which rendered the treatment of urinary tract infections more difficult.

  • Perseverant bacteria challenge antibacterial treatment

    Bacterial perseverance is a new phenomenon that helps explain how bacteria adapt to survive antibiotic treatments. A group of researchers at Uppsala University have studied how individual bacteria react when exposed to different antibiotics. The result underlines the importance of adhering strictly to antibiotic prescriptions.

  • Widespread metabolic dysregulation in different organs in type 2 diabetes

    Using state of the art techniques, researchers from Uppsala University have shown that the metabolism in patients with type 2 diabetes and prediabetes was much more disturbed than previously known, and that it varied between organs and with the severity of the disease. The study, a collaboration with Copenhagen University and AstraZeneca, among others, has been published in Cell Reports Medicine.

  • Strong link between gut bacteria and metabolites

    There are strong links between bacteria living in the gut and the levels of small molecules in the blood known as metabolites. Such is the finding of a new study (Uppsala University/Lund University). The study is based on analyses of both fecal and blood samples from 8,583 participants in the Swedish CArdioPulmonary bioImage Study (SCAPIS).

  • Genetic background associated with physically active lifestyle

    In a large international study, researchers at Uppsala University have identified DNA regions that are associated with physical activity or leisure screen time. The findings confirm that physical activity is beneficial for health and suggest that a more sedentary lifestyle can be explained by how muscles respond to exercise.

  • Blood clot formation in cerebral cavernous malformations

    In the condition known as cerebral cavernoma, lesions arise in a cluster of blood vessels in the brain. In a new study from Uppsala University, researchers show that blood coagulation and blood clot formation are very relevant for the disease and that antithrombotic therapy may be beneficial for cavernoma patients.

  • New hypothesis about crocodiles’ ears may help people with impaired hearing

    Impaired hearing affects billions of people, but crocodiles, who live almost as long and can surpass 70 years of age, have good hearing throughout their lives. One reason is because can create new hair cells, and a research group from Uppsala University is now on the path to finding out why. Hopefully, knowledge from the world of crocodiles will be able to help people with impaired hearing.

  • Oral contraceptives and hormone therapy increase the risk of stroke

    Oral contraceptives and hormone therapy at menopause increase the risk of stroke. The increased risk is greatest during the first year of treatment and then declines. The study, which is now published in Stroke, is based on data from over a quarter of a million women from the UK Biobank database.

  • Newly discovered coronavirus common in bank voles

    Researchers from the Zoonosis Science Center at Uppsala University have identified a new coronavirus. Their study of approximately 260 bank voles caught around Grimsö, Örebro County, shows that the virus is well established in Sweden’s red-backed voles. The finding has been published in the journal Viruses.

  • Rare genetic variants not the major contributing factors to common diseases

    Although some rare genetic variants can increase the risk of disease markedly for a few individuals, the genetic contribution to common diseases is mostly due to a combination of many common genetic variants with small effects. This is shown in a comprehensive study by researchers at Uppsala University and SciLifeLab, published in the journal Nature Communications.

  • MS patients with higher B cell counts have a better vaccine response

    MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study from Uppsala University published in the journal JAMA Network Open. In patients with B cell counts of 40/µL (microlitres) or more, 9 of 10 patients developed protective levels of antibodies, while significantly fewer with lower counts had similar respon

Show more